Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q3

7133.TEDINET S100SUOD
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 37
MetricValuePeriodScopeSource row
Revenue¥6.1bn2023-04-01 → 2023-12-31StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥4.9bn2022-04-01 → 2022-12-31StandaloneNet sales
Operating income¥466m2023-04-01 → 2023-12-31StandaloneOperating income
Operating income¥398m2022-04-01 → 2022-12-31StandaloneOperating income
Ordinary income¥467m2023-04-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥406m2022-04-01 → 2022-12-31StandaloneOrdinary income
Profit before tax¥467m2023-04-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥384m2022-04-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥317m2023-04-01 → 2023-12-31StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥260m2022-04-01 → 2022-12-31StandaloneProfit loss
Total assets¥3.9bnat 2023-12-31StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥3.0bnat 2022-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥2.4bnat 2023-12-31StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.4bnat 2022-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥581mat 2023-12-31StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
EPS (basic)¥44.532023-04-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.872023-10-01 → 2023-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥36.72022-04-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.382022-10-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥42.442023-04-01 → 2023-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥34.522022-04-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
Equity ratio38.4%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio45.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued7,172,800at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,571,700at 2022-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥6m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥320m
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2023-12-31¥4.9bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2023-12-31¥4.9bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2023-12-31¥470m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue2023-04-01 → 2023-12-31¥620m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue external2023-04-01 → 2023-12-31¥620m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentsegment profit2023-04-01 → 2023-12-31¥360m
jpcrp040300-q3r_E37198-000Primary Care Homereportable segmentrevenue2023-04-01 → 2023-12-31¥564m
jpcrp040300-q3r_E37198-000Primary Care Homereportable segmentrevenue external2023-04-01 → 2023-12-31¥564m
jpcrp040300-q3r_E37198-000Primary Care Homereportable segmentsegment profit2023-04-01 → 2023-12-31−¥39m
—segment totalrevenue2023-04-01 → 2023-12-31¥6.1bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥6.1bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥791m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥786m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥38m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥38m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥3m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥297m
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-12-31¥4.3bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-12-31¥4.3bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-12-31¥510m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-12-31¥461m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-12-31¥461m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-12-31¥259m
jpcrp040300-q3r_E37198-000Primary Care Homereportable segmentrevenue2022-04-01 → 2022-12-31¥99m
jpcrp040300-q3r_E37198-000Primary Care Homereportable segmentrevenue external2022-04-01 → 2022-12-31¥99m
jpcrp040300-q3r_E37198-000Primary Care Homereportable segmentsegment profit2022-04-01 → 2022-12-31−¥77m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.9bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.9bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥692m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥695m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 313
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)宮　本　芳　樹
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)下　平　雅　和
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember4921959000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember6096216000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember6657448000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember406466000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember466686000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember557751000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember260130000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember316912000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember382876000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember185854000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember188493000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember185912000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember3571700
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember7172800
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember3572000
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1360273000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1505231000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1483134000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember3011356000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember3915155000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember2914911000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember36.70
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember44.53
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember53.92
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember34.52
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember42.44
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember50.82
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember－
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.452
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.384
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.509
Basic earnings loss per share (5-year summary)Prior1QuarterDuration_NonConsolidatedMember11.38
Basic earnings loss per share (5-year summary)CurrentQuarterDuration_NonConsolidatedMember25.87
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember7172800
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember7236400
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant7172800
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant7236400
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass